| scholarly article | Q13442814 |
| P50 | author | Yoshihiro Kawaoka | Q2600945 |
| Kiyoko Iwatsuki-Horimoto | Q66750947 | ||
| P2093 | author name string | Taisuke Horimoto | |
| Hiroaki Katsura | |||
| Shinji Watanabe | |||
| Kazunori Oishi | |||
| Yukihiro Akeda | |||
| Zhenyu Piao | |||
| P2860 | cites work | Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine | Q22250891 |
| Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness | Q24647318 | ||
| RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates | Q27861007 | ||
| 5'-Triphosphate RNA is the ligand for RIG-I | Q28131726 | ||
| Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA | Q28513215 | ||
| Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis | Q29011885 | ||
| Generation of influenza A viruses entirely from cloned cDNAs | Q29616768 | ||
| Insights into the interaction between influenza virus and pneumococcus | Q30355570 | ||
| Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. | Q30366558 | ||
| Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. | Q30377205 | ||
| Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. | Q30384053 | ||
| Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections | Q30385165 | ||
| Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity | Q30421682 | ||
| Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications | Q33769373 | ||
| Potential role for mucosally active vaccines against pneumococcal pneumonia | Q33792681 | ||
| Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 | Q34129986 | ||
| Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections | Q34885060 | ||
| Next generation pneumococcal vaccines | Q35028495 | ||
| ??? | Q28142317 | ||
| Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus | Q35173733 | ||
| Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines | Q35629114 | ||
| Streptococcus pneumoniae colonisation: the key to pneumococcal disease | Q35681330 | ||
| Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface | Q36228991 | ||
| Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production | Q36497698 | ||
| Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes | Q36525136 | ||
| Unveiling molecular mechanisms of bacterial surface proteins: Streptococcus pneumoniae as a model organism for structural studies | Q36905504 | ||
| A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. | Q36990047 | ||
| Protection against lethal influenza with a viral mimic | Q37036766 | ||
| The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease | Q37109940 | ||
| The future of pneumococcal disease prevention | Q39707818 | ||
| Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci | Q40387059 | ||
| A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine | Q41997487 | ||
| Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae. | Q43078345 | ||
| Toll-like receptor 3 promotes cross-priming to virus-infected cells. | Q45511446 | ||
| Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1 /80 (H7N7) influenza virus | Q45805094 | ||
| Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import | Q45854241 | ||
| Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice | Q47790283 | ||
| Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice | Q56897607 | ||
| Toll-dependent selection of microbial antigens for presentation by dendritic cells | Q59063722 | ||
| Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine | Q71825810 | ||
| Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules | Q73502898 | ||
| Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers | Q73509127 | ||
| Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae | Q73688169 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Streptococcus pneumoniae | Q221179 |
| P304 | page(s) | 13410-13417 | |
| P577 | publication date | 2014-09-10 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection | |
| P478 | volume | 88 |
| Q30245071 | Acute otitis media with spontaneous tympanic membrane perforation |
| Q35197120 | Complement evasion by Bordetella pertussis: implications for improving current vaccines |
| Q38556537 | Development and applications of single-cycle infectious influenza A virus (sciIAV). |
| Q38663438 | Mathematical modeling of postcoinfection with influenza A virus and Streptococcus pneumoniae, with implications for pneumonia and COPD-risk assessment |
| Q37130191 | Next generation protein based Streptococcus pneumoniae vaccines |
| Q64116962 | Novel Approaches for The Development of Live Attenuated Influenza Vaccines |
| Q28076140 | Reverse Genetics Approaches for the Development of Influenza Vaccines |
| Q30380503 | The role of influenza in the epidemiology of pneumonia |
Search more.